FOXD4 | Forkhead box D4 | Transcription factors
| | | | | Not detected |
CBWD1 | COBW domain containing 1 | | | | | | Expressed in all |
C9orf66 | Chromosome 9 open reading frame 66 | | | | | | Tissue enriched |
DOCK8 | Dedicator of cytokinesis 8 | Disease related genes
| | | | | Expressed in all |
KANK1 | KN motif and ankyrin repeat domains 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
DMRT1 | Doublesex and mab-3 related transcription factor 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
DMRT3 | Doublesex and mab-3 related transcription factor 3 | Transcription factors
| | | | | Tissue enhanced |
DMRT2 | Doublesex and mab-3 related transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
VLDLR | Very low density lipoprotein receptor | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNV2 | Potassium channel, subfamily V, member 2 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KIAA0020 | KIAA0020 | | | | | | Expressed in all |
RFX3 | Regulatory factor X, 3 (influences HLA class II expression) | Transcription factors
| | | | | Tissue enhanced |
AL365202.1 | Uncharacterized protein | | | | | | Not detected |
GLIS3 | GLIS family zinc finger 3 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
SLC1A1 | Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SPATA6L | Spermatogenesis associated 6-like | | | | | | Tissue enhanced |
PPAPDC2 | Phosphatidic acid phosphatase type 2 domain containing 2 | Predicted membrane proteins
| | | | | Mixed |
CDC37L1 | Cell division cycle 37-like 1 | | | | | | Expressed in all |
AK3 | Adenylate kinase 3 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
RCL1 | RNA terminal phosphate cyclase-like 1 | Plasma proteins
| | | | | Expressed in all |
AL158147.2 | HCG2011465; Uncharacterized protein | | | | | | Group enriched |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
AL161450.1 | Uncharacterized protein | | | | | | Not detected |
INSL6 | Insulin-like 6 | Predicted secreted proteins
| | | | | Tissue enriched |
INSL4 | Insulin-like 4 (placenta) | Predicted secreted proteins
| | | | | Tissue enriched |
RLN2 | Relaxin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
RLN1 | Relaxin 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLGRKT | Plasminogen receptor, C-terminal lysine transmembrane protein | Mitochondrial proteins
| | | | | Expressed in all |
CD274 | CD274 molecule | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
PDCD1LG2 | Programmed cell death 1 ligand 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Mixed |
KIAA1432 | KIAA1432 | Predicted membrane proteins
| | | | | Expressed in all |
ERMP1 | Endoplasmic reticulum metallopeptidase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
KIAA2026 | KIAA2026 | | | | | | Expressed in all |
MLANA | Melan-A | Predicted membrane proteins
| | | | | Tissue enriched |
RANBP6 | RAN binding protein 6 | | | | | | Expressed in all |
IL33 | Interleukin 33 | | | | | | Mixed |
TPD52L3 | Tumor protein D52-like 3 | | | | | | Tissue enriched |
UHRF2 | Ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase | Disease related genes
| | | | | Expressed in all |
C9orf38 | Chromosome 9 open reading frame 38 | | | | | | Not detected |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
KDM4C | Lysine (K)-specific demethylase 4C | Plasma proteins
| | | | | Expressed in all |
TMEM261 | Transmembrane protein 261 | Predicted membrane proteins
| | | | | Expressed in all |
PTPRD | Protein tyrosine phosphatase, receptor type, D | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TYRP1 | Tyrosinase-related protein 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
LURAP1L | Leucine rich adaptor protein 1-like | | | | | | Mixed |
MPDZ | Multiple PDZ domain protein | Disease related genes Plasma proteins
| | | | | Mixed |
NFIB | Nuclear factor I/B | Cancer-related genes Transcription factors
| | | | | Mixed |
ZDHHC21 | Zinc finger, DHHC-type containing 21 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CER1 | Cerberus 1, DAN family BMP antagonist | Predicted secreted proteins
| | | | | Not detected |